A 29-year-old womandeveloped hypopituitarism following removal of a pituitary chromophobe adenoma, and this was complicated by type V hyperlipidemia and obesity.
removedat another hospital, and operation was followed by radiotherapy for 3 months (total dose 6,000 rad). Her body weight at that time was 48 kg.
Her menarche occurred at age ll, and her menses were normal until one and half years before surgery when amenorrhoea developed. No hyperlipidemia was noted either before or 6 months after surgery (total cholesterol 175 mg/dl). Eight years after operation the patient was found to have hyperlipidemia (milky serum + total cholesterol 459 mg/dl). She had married at the age of 25 but never pregnant. Her body weight had increased about 10 kg in the past 4 years, but no other new symptoms were noted. The patient was referred to Fukuoka University Hospital for evaluation of her hyperlipidemia (serum total cholesterol and triglyceride levels at the outpatient examination were 398 mg/dl and 1,880 mg/dl, respectively).
On admission, she was noted to be an obese womanwith a height of 151 cm and a weight of 64.8 kg. Her appearance was otherwise normal. The pulse rate was 72/min, and the blood pressure 90/60 mmHg.There were no xanthoma to present. The face, lungs, heart, abdomenand extremities were clinically normal and neurological, examination was unremarkable.
Urinalysis was normal, the hematocrit was 37.8%, and the white cell count was 4,600. Total cholesterol level was 370 mg/dl, while triglyceride were 1,008 mg/dl. The HDLcholesterol level was 32 mg/dl, the apolipoprotein (apo) A-I level was 132 mg/dl, the apo A-II level was 32.2 mg/dl, and the apo B level was 116 mg/dl. The S-GPT was 20 IU/1, alkaline phosphatase level 97 IU/1, r-GTP level 49 IU/1, cholinesterase 159 IU/1, glucose 89 mg/dl, and serum amylase 49 IU/1. The serum sodium was 140 mEq/1, potassium 3.7 mEq/1, and chloride 102 mEq/1. The LH-RH provocation test showed a low response of LH and FSH (Table 1) . The TRHtest showed a low-normal response of TSH and a delayed response of PRL (Table 1 ). The GRF test showed a low GH response (Table 1) . The lysine-vasopressin test showed a low response of ACTH (Table 1) . Insulin tolerance test also showed a low response of ACTHand GH( Table 3 ). The T3 was 1.0 ng/ml, T4 was 5.7 /ig/dl, the Triosorb test 24.2%, TSH was 1.7^U/ml, and free T4was Gonadal : Progesterone, ng/ml Estradiol (E2), pg/ml 0.9 /ig/dl ( Table 2 ). The serum cortisol was ll.3 fx g/d\ at 8:00 AM.The urinary 17-KS excretion level was 2.7 mg/day, and 17-OHCSexcretion was 4.4 mg/day. Her progesterone level was 0.4 ng/ml, while the estradiol was < 5.0 pg/ml ( Table 2 ). The oral glucose tolerance test (75 g) showed impaired glucose tolerance and an exaggerated insulin response ( Table 4) . Computedtomography of the head showedenlargementof the sella turcica. Plain X-rayof the sella turcica also showed enlargement of the sella and a double floor. Abdominal ultra- spectively, to 267 mg/dl and 213 mg/dl. Later the triglyceride levels varied between 267 and 1,000 mg/dl, while total cholesterol levels remained slightly raised. The phenotype of apo E, determined by isoelectric focusing gel electrophoresis of VLDL, was homozygous for E3. Lipoprotein analysis (Table 5) showed a marked increase in cholesterol and triglyceride in the VLDLfraction. An increase in her calorie intake from 700 kcal/day to 1 ,200 kcal/day resulted in a marked increase in the triglyceride level to 1 ,006 mg/dl. Postheparin plasma lipolytic activity was investigated according to a modification of the adenoma. Although the basal prolactin level was slightly elevated, the existence of a prolactinoma was unlikely, because the prolactin level was less than 100 ng/ml and no mass was found in the sella turcica on either skull x-ray or computed tomography. The patient was diagnosed as having type V hyperlipidemia. Type III hyperlipidemia was ruled out from the apo E phenotype and low VLDL cholesterol to VLDLtriglyceride ratio. It is known that hypopituitarism is accompanied by hypertriglyceridemia as well as hypercholesterolemia (Type IV, V, lib) (1-6). Zollner (1) and Tabatznik (2) 
